HAE Stock Ownership Activity

HAEMONETICS CORP/MASS 13F holders

No value investing guru has made any change to the HAEMONETICS CORP/MASS (HAE) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying HAE now?

According to the latest SEC filing(s) HAEMONETICS CORP/MASS (HAE) has not been purchased by any super investor.

To see more about who is investing in HAEMONETICS CORP/MASS (HAE), please go to the HAE ownership page.

2014 Q2 (1 result)
Robert Olstein
-100.00%
-14,400
-0.06%
0.00%
Current price: $85.54 162.64% Reported price*: $32.57
2014 Q1 (2 results)
Robert Olstein
buy
+14,400
+0.06%
0.00%
Marty Whitman
-100.00%
-42,000
-0.03%
0.00%
Current price: $85.54 136.13% AVG reported price*: $36.23
2013 Q2 (1 result)
Marty Whitman
buy
+40,530
+0.03%
0.03%
Current price: $85.54 106.83% Reported price*: $41.36
4 of 4

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.